Identifying therapeutic targets in low‐grade serous ovarian carcinomas with no specific molecular profile

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Kathleen I Pishas, Karla J Cowley, Evanny Marinovic, Martin Köbel, Marta Llaurado‐Fernandez, Hannah Kim, Shaine Chenxin Bao, Dalia Mizikovsky, Nathan J Palpant, Raunak Shrestha, Robert Vary, Jennii Luu, Liliane Meunier, Timothy Semple, Pilar Blancafort, Emily Golden, Paul A Cohen, Mark S Carey, Ian G Campbell, Kaylene J Simpson, Dane Cheasley
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	The Journal of Pathology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

B cells critical for outcome in high grade serous ovarian carcinoma
by: Annegé Vledder, et al.
Published: (2024)

Molecular and immunohistochemical characterization of ERBB2 activating mutations in low‐grade serous ovarian carcinoma
by: Alexander J Neil, et al.
Published: (2025)

Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer
by: Joshua S Cheruvathur, et al.
Published: (2025)

Comparing languages from vocabulary growth to inflection paradigms: A study run on parallel corpora and multilingual lexicons
by: Helena Blancafort
Published: (2008)

ACERCA DE LA FUNCIONALIDAD DE SETAS COMESTIBLES PLEUROTUS SPP.: PROPIEDADES BIOESTIMULANTES DE UN EXTRACTO ACUOSO
by: G. Llauradó
Published: (2005)

A resource management system for transmission capacity enhancement in wireless mesh networks
by: Christian Köbel
Published: (2016)

Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma
by: Xiaojiang Wang, et al.
Published: (2024)

Las actividades de los libros de texto de química para la teoría corpuscular y su contribución a la evolución de los modelos explicativos
by: Ainoa Marzábal Blancafort
Published: (2012)

ALGUNAS ORIENTACIONES PARA ENSEÑAR CIENCIAS NATURALES EN EL MARCO DEL NUEVO ENFOQUE CURRICULAR
by: Ainoa Marzábal Blancafort
Published: (2011)

Changes in lipid metabolism and plasma concentrations of thyroxine, cortisol, and somatostatin in land-locked chinook salmon, Oncorhynchus tshawytscha, during smoltification / Darrin J. Cowley
by: Cowley, Darrin .J
Published: (1990)

Risk-Neutral Compression and the Geometry of Latent Market Stress
by: Vidal Llauradó, Joan
Published: (2026)

La risa de fuego: Un análisis antropológico sobre el papel trasgresor del fuego en la creación artística
by: Jaime Repollés-Llauradó
Published: (2014)

Room-temperature optically detected coherent control of molecular spins
by: Mena, Adrian, et al.
Published: (2024)

How to make dermatology conferences more sustainable?
by: Branka Marinovic
Published: (2025)

Pintando desde las raíces
by: Mimí Marinovic
Published: (2007)

Circulating serum miRNAs predict response to platinum chemotherapy in high‐grade serous ovarian cancer
by: Kazuhiro Suzuki, et al.
Published: (2024)

Spatially resolved proteomics surveys the chemo‐refractory proteins related to high‐grade serous ovarian cancer
by: Linyuan Fan, et al.
Published: (2025)

Tailored chemotherapy: Innovative deep‐learning model customizing chemotherapy for high‐grade serous ovarian carcinoma
by: Se Ik Kim, et al.
Published: (2024)

Cellular origins of mucinous ovarian carcinoma
by: Nicola S Meagher, et al.
Published: (2025)

Hipsterism
by: Semple, Tara
Published: (2022)

Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database
by: Xianglin Nie, et al.
Published: (2024)

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer
by: Sophia Bielesch, et al.
Published: (2026)

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer
by: Laura Glossner, et al.
Published: (2025)

Plasma‐activated media selectively induces apoptotic death via an orchestrated oxidative stress pathway in high‐grade serous ovarian cancer cells
by: Lorena T. Davies, et al.
Published: (2024)

Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells
by: Olivier Romito, et al.
Published: (2024)

Identification of potential cell surface targets in patient‐derived cultures toward photoimmunotherapy of high‐grade serous ovarian cancer
by: Sudip Timilsina, et al.
Published: (2025)

Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high‐grade serous ovarian carcinoma
by: Amanda Olsson Widjaja, et al.
Published: (2025)

Las Higueras: An Overture to the Alternation of Customizing Incremental Houses
by: Goran Ivo Marinovic
Published: (2021)

From Sycophancy to Sensemaking: Premise Governance for Human-AI Decision Making
by: Jain, Raunak
Published: (2026)

Collaborative Causal Sensemaking: Closing the Complementarity Gap in Human-AI Decision Support
by: Jain, Raunak
Published: (2025)

Zero-shot Factual Consistency Evaluation Across Domains
by: Agarwal, Raunak
Published: (2024)

Single-cell transcriptomic analysis reveals intra-tumoral heter-ogeneity and immunotherapy strategies in high-grade serous ovarian cancer
by: wu, wenjuan
Published: (2026)

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7 ‐ H3
by: Aya Saleh, et al.
Published: (2026)

Development and validation of a computational tool to predict treatment outcomes in cells from high‐grade serous ovarian cancer patients
by: Marilisa Cortesi, et al.
Published: (2025)

Networking and an Art Library.
by: Dane, William J.
Published: (1983)

Organizational Patterns in Public Libraries
by: Dane, William J.
Published: (1975)

Mechanistic interpretability for steering vision-language-action models
by: Häon, Bear, et al.
Published: (2025)

Speckle Tracking Echocardiography for Global Longitudinal Strain—Have Modern Strain Packages Improved Reproducibility?
by: Rebecca Perry, et al.
Published: (2026)

A case of BRAF mutation‐positive recurrent ovarian high‐grade serous carcinoma with remarkable response to combined dabrafenib and trametinib therapy
by: Tatsuhito Furui, et al.
Published: (2025)

Rates of genetic consultation in high‐grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population‐based study
by: Shannon E. Brent, et al.
Published: (2024)